LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, announced today that its representatives plan to attend MEDICA 2026 in Dusseldorf, Germany, one of the world’s largest international healthcare and medical technology trade fairs. The company said attendance is intended to support ongoing evaluation of healthcare technologies, strategic industry relationships, vendor solutions, digital infrastructure initiatives, and broader commercialization opportunities associated with its developing healthcare technology ecosystem.
MEDICA, held annually in Dusseldorf, attracts thousands of exhibitors and visitors from around the globe, making it a key event for companies seeking to stay at the forefront of medical technology. LataMed AI plans to engage with healthcare technology providers, telehealth vendors, pharmaceutical infrastructure participants, medical software developers, AI-focused healthcare companies, and other industry stakeholders operating throughout Europe, Latin America, and additional international markets. The company believes participation in such events may provide opportunities to evaluate emerging technologies, support industry relationship development, and advance its long-term digital healthcare infrastructure strategy across Latin America and other developing markets.
Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., stated: “Healthcare systems around the world are rapidly moving toward technology-driven and AI-enabled infrastructure models. Our attendance at MEDICA reflects our commitment to engaging with industry participants, evaluating emerging technologies, and continuing to build a scalable healthcare platform designed to support long-term digital healthcare modernization initiatives throughout Latin America.”
The company remains in the development and commercialization stage with respect to certain aspects of its healthcare technology platform and business operations. LataMed AI cautioned that attendance at industry conferences and trade fairs does not guarantee strategic relationships, commercial agreements, financing arrangements, technology integrations, revenue generation, or future operational success. The company continues to advance telehealth deployment initiatives, healthcare analytics integration, operational scalability planning, strategic relationship development, and broader commercialization efforts associated with its long-term digital healthcare ecosystem strategy throughout Latin America.
LataMed AI Corp. is a development-stage digital health and artificial intelligence technology company focused on developing scalable telehealth infrastructure and healthcare analytics platforms for emerging markets, with an initial emphasis on Latin America. The company is advancing a technology-enabled healthcare ecosystem designed to support remote patient engagement, provider coordination, healthcare analytics, emergency response integration, pharmaceutical logistics, and broader digital healthcare delivery initiatives. Through telehealth infrastructure development, artificial intelligence-driven healthcare technologies, regulatory progression initiatives, strategic relationships, and operational expansion efforts, LataMed AI Corp. is positioning itself to participate in the ongoing modernization and digital transformation of healthcare delivery systems across emerging markets.
For more information, visit https://latamed.ai, follow the Company’s official Instagram page at https://www.instagram.com/latamedai, or review the Company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov.
